To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SFRS8TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
393 supporting clones for gene SFRS8 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC144364 Brain, cerebellum, PCR rescued clones .a 1 to 3219 1 to 3219 L421P tiling clone,   3219/3219
(100 %)
2 diff
(100.0 %id)
TI_2194645528   .a 2042 to 3219 1219 to 55     Submitted on the opposite strand 1165/1281
(90 %)
22 diff
(98.3 %id)
BG122471 adenocarcinoma, cell line, Liver .a 2060 to 2656 8 to 617       610/1157
(52 %)
18 diff
(98.5 %id)
TI_2194644740   .a 2066 to 3219 1201 to 57     Submitted on the opposite strand 1145/1272
(90 %)
27 diff
(97.9 %id)
BE884950 leiomyosarcoma, uterus .a 2148 to 2925 1 to 767       767/874
(87 %)
32 diff
(96.4 %id)
BF856908 prostate_tumor .a 2195 to 2604 412 to 4     Submitted on the opposite strand 409/412
(99 %)
0 diff
(100 %id)
BC024041 Eye, retinoblastoma .b 1 to 1928 1 to 1928   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1928/1973
(97 %)
4 diff
(99.8 %id)
BG281964 melanotic melanoma, skin .b 1 to 896 1 to 887       807/889
(90 %)
24 diff
(97.4 %id)
BC008707 Skin, melanotic melanoma. .b 2 to 2400 1 to 2399   available from MGC, AAA   2399/2399
(100 %)
4 diff
(99.9 %id)
BC015953 Skin, melanotic melanoma. .b 2 to 2400 1 to 2399   available from MGC, AAA   2399/2399
(100 %)
4 diff
(99.9 %id)
NM_004592.2   .b 2 to 3246 1 to 3245 exact RefSeq,   3245/3245
(100 %)
1 diff
(100.0 %id)
BU147058 eye, normal pigmented retinal epithelium .b 3 to 820 33 to 858       826/939
(87 %)
13 diff
(98.7 %id)
BU553501 ovary, teratocarcinoma, cell line .b 3 to 810 1 to 814   tiling clone,   814/894
(91 %)
14 diff
(98.5 %id)
BU553897 ovary, teratocarcinoma, cell line .b 3 to 800 1 to 802       802/934
(85 %)
21 diff
(97.8 %id)
DB139445 thymus .b 3 to 258 2 to 258   capped   257/257
(100 %)
2 diff
(99.3 %id)
BE410359 choriocarcinoma, placenta .b 5 to 741 1 to 737       737/781
(94 %)
25 diff
(96.8 %id)
BU166998 melanotic melanoma, skin .b 7 to 747 67 to 814       749/877
(85 %)
15 diff
(98.3 %id)
AA242926 brain, neuroepithelial cells .b 8 to 357 1 to 350       350/350
(100 %)
18 diff
(94.9 %id)
BQ947342 sciatic nerve .b 10 to 867 23 to 890       868/915
(94 %)
18 diff
(98.1 %id)
AA280946 germinal center B cell .b 11 to 499 1 to 483       483/483
(100 %)
14 diff
(97.2 %id)
BF307456 muscle, rhabdomyosarcoma .b 20 to 695 1 to 677       677/677
(100 %)
12 diff
(98.3 %id)
AL524252 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 21 to 561 1 to 541       541/541
(100 %)
9 diff
(98.4 %id)
BE277665 melanotic melanoma, skin .b 21 to 747 1 to 742       742/750
(98 %)
26 diff
(96.6 %id)
BE408632 choriocarcinoma, placenta .b 21 to 479 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
BE729682 melanotic melanoma, skin .b 21 to 808 1 to 783       781/941
(82 %)
25 diff
(97.4 %id)
BM478388 eye, retinoblastoma .b 21 to 743 1 to 730       730/1110
(65 %)
16 diff
(98.6 %id)
BU176850 eye, retinoblastoma .b 21 to 915 1 to 901       901/901
(100 %)
19 diff
(97.9 %id)
BE274645 melanotic melanoma, skin .b 22 to 836 1 to 810       810/819
(98 %)
16 diff
(98.1 %id)
U08377 placenta .b 22 to 3246 1 to 3225 L52Q L136F R236P L421P H493Y     3225/3225
(100 %)
11 diff
(99.7 %id)
BE274686 melanotic melanoma, skin .b 26 to 813 1 to 781       781/806
(96 %)
30 diff
(96.3 %id)
BU553459 ovary, teratocarcinoma, cell line .b 26 to 894 1 to 877       877/881
(99 %)
15 diff
(98.3 %id)
BU855612 ovary, teratocarcinoma, cell line .b 26 to 747 1 to 729       729/909
(80 %)
9 diff
(99.1 %id)
TI_1959501489   .b 42 to 404 374 to 12       363/1318
(27 %)
4 diff
(99.7 %id)
TI_1959503259   .b 42 to 1195 54 to 1195     Submitted on the opposite strand 1142/1281
(89 %)
14 diff
(99.0 %id)
TI_2194644751   .b 42 to 1140 59 to 1147     Submitted on the opposite strand 1089/1256
(86 %)
15 diff
(98.9 %id)
TI_2194645909   .b 42 to 1089 57 to 1097     Submitted on the opposite strand 1041/1268
(82 %)
13 diff
(99.0 %id)
BE409788 choriocarcinoma, placenta .b 44 to 528 128 to 630       503/778
(64 %)
15 diff
(98.1 %id)
BF982536 duodenal adenocarcinoma, cell line, small intestine .b 45 to 899 1 to 859       857/869
(98 %)
34 diff
(96.1 %id)
BE795540 lung, small cell carcinoma .b 47 to 838 1 to 790       790/886
(89 %)
16 diff
(98.2 %id)
BC136678 Brain, cerebellum, PCR rescued clones .b 49 to 3109 1 to 3061 L421P tiling clone,   3061/3061
(100 %)
2 diff
(100.0 %id)
BQ424349 leiomyosarcoma, uterus .b 50 to 918 1 to 875       875/875
(100 %)
8 diff
(99.1 %id)
BQ073686 epidermoid carcinoma, cell line, lung .b 90 to 938 1 to 857       857/995
(86 %)
14 diff
(98.6 %id)
BU528233 epidermoid carcinoma, cell line, lung .b 90 to 973 1 to 896   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 896/934
(95 %)
16 diff
(98.3 %id)
BU184997 melanotic melanoma, cell line, skin .b 116 to 887 1 to 772       772/883
(87 %)
5 diff
(99.5 %id)
BQ682794 melanotic melanoma, cell line, skin .b 116 to 889 1 to 772       772/884
(87 %)
11 diff
(98.8 %id)
TI_1959501477   .b 158 to 1331 1173 to 13       1166/1305
(89 %)
32 diff
(97.6 %id)
BG425307 Kidney, renal cell adenocarcinoma .b 172 to 456 1 to 290       290/292
(99 %)
8 diff
(97.3 %id)
BM051391 eye, normal pigmented retinal epithelium .b 217 to 747 215 to 768       730/928
(78 %)
51 diff
(94.6 %id)
AW411150 muscle, rhabdomyosarcoma .b 306 to 437 1 to 132       132/132
(100 %)
0 diff
(100 %id)
AI023864 liver and spleen .b 385 to 964 581 to 1       581/581
(100 %)
7 diff
(98.8 %id)
BG747042 adenocarcinoma cell line, colon .b 416 to 1108 1 to 693       693/693
(100 %)
3 diff
(99.6 %id)
BM012487 brain, neuroblastoma, cell line .b 468 to 1091 1 to 625       625/793
(78 %)
15 diff
(98.2 %id)
TI_59381701   .b 468 to 1091 110 to 734       625/793
(78 %)
15 diff
(98.2 %id)
BE218481 carcinoid, lung .b 496 to 963 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AA280850 germinal center B cell .b 500 to 966 467 to 1       467/468
(99 %)
1 diff
(99.8 %id)
CR997288 T-Lymphocytes .b 504 to 1347 1 to 848       848/848
(100 %)
7 diff
(99.2 %id)
TI_1959498552   .b 526 to 1195 544 to 1206     Submitted on the opposite strand 663/729
(90 %)
13 diff
(98.3 %id)
AI089775 brain, glioblastoma (pooled) .b 526 to 973 453 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 449/453
(99 %)
1 diff
(99.8 %id)
AI357385 brain, glioblastoma (pooled) .b 526 to 973 447 to 2       446/447
(99 %)
6 diff
(98.7 %id)
AI356131 brain, glioblastoma (pooled) .b 526 to 966 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
BI013067 lung_tumor .b 549 to 803 256 to 1       256/258
(99 %)
16 diff
(93.8 %id)
AW206636   .b 584 to 973 398 to 9   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 390/398
(97 %)
0 diff
(100 %id)
BF315594 brain, neuroblastoma .b 587 to 1322 1 to 731       731/765
(95 %)
22 diff
(97.2 %id)
BI200012 brain, neuroblastoma .b 587 to 1191 1 to 620       620/633
(97 %)
22 diff
(96.6 %id)
TI_1959501475   .b 590 to 1809 1212 to 1       1212/1318
(91 %)
30 diff
(97.8 %id)
AA587895 colon, colon tumor RER+ .b 597 to 961 365 to 1       365/394
(92 %)
27 diff
(93.2 %id)
TI_1243020129   .b 617 to 1550 6 to 938       933/1150
(81 %)
11 diff
(99.1 %id)
BF375133 stomach .b 635 to 1126 1 to 491       491/491
(100 %)
16 diff
(96.8 %id)
TI_1243019297   .b 665 to 1552 1004 to 129       880/1211
(72 %)
17 diff
(98.6 %id)
BG749014 eye, normal pigmented retinal epithelium .b 731 to 1357 1 to 627       627/627
(100 %)
3 diff
(99.6 %id)
BG749092 eye, normal pigmented retinal epithelium .b 731 to 1428 1 to 704       704/881
(79 %)
21 diff
(97.7 %id)
TI_59381393   .b 736 to 1372 95 to 733       639/761
(83 %)
16 diff
(97.9 %id)
AI565376 Kidney .b 744 to 954 212 to 1       212/224
(94 %)
4 diff
(98.3 %id)
BM012191 brain, neuroblastoma, cell line .b 747 to 1372 14 to 640       627/762
(82 %)
8 diff
(99.0 %id)
BF833735 head_neck .b 793 to 1123 349 to 19     Submitted on the opposite strand 331/356
(92 %)
11 diff
(97.0 %id)
CU443067 epidermis .b 799 to 1169 379 to 9     Submitted on the opposite strand 371/387
(95 %)
9 diff
(97.7 %id)
BF354252 head_neck .b 804 to 1196 398 to 5       394/412
(95 %)
9 diff
(97.9 %id)
BX389464 Placenta Cot 25-normalized .b 864 to 1780 10 to 917       908/917
(99 %)
28 diff
(97.0 %id)
BF688179 eye, normal pigmented retinal epithelium .b 881 to 1456 1 to 570       570/956
(59 %)
15 diff
(98.5 %id)
BG752274 eye, normal pigmented retinal epithelium .b 881 to 1570 1 to 689       689/861
(80 %)
19 diff
(97.8 %id)
BF238020 B-cells, primary B-cells from tonsils (cell line) .b 898 to 1402 1 to 504       504/994
(50 %)
10 diff
(99.0 %id)
BE744404 adenocarcinoma cell line, ovary .b 940 to 1501 1 to 555       558/572
(97 %)
15 diff
(97.4 %id)
TI_59393323   .b 940 to 1731 85 to 884       800/801
(99 %)
32 diff
(96.1 %id)
BM015199 breast, mammary adenocarcinoma, cell line .b 941 to 1731 1 to 799       799/800
(99 %)
32 diff
(96.0 %id)
BE745080 adenocarcinoma cell line, ovary .b 951 to 1502 1 to 546       550/750
(73 %)
11 diff
(98.6 %id)
H44689 breast .b 955 to 1329 1 to 379       379/381
(99 %)
6 diff
(98.5 %id)
AA256873 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1015 to 1326 1 to 311       311/311
(100 %)
2 diff
(99.4 %id)
CR991818 T-Lymphocytes .b 1015 to 1694 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
CN286321 embryonic stem cells, cell lines H1, H7, andH9 .b 1023 to 1689 1 to 667       667/667
(100 %)
4 diff
(99.5 %id)
CN286315 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1089 to 1514 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
AA814050 germinal center B cell .b 1173 to 1503 333 to 5   tiling clone,   329/333
(98 %)
4 diff
(98.8 %id)
BU537965 adenocarcinoma, cell line, breast .b 1288 to 2223 1 to 936       936/937
(99 %)
14 diff
(98.6 %id)
CR982750 T-Lymphocytes .b 1456 to 2318 1 to 866       866/867
(99 %)
7 diff
(99.2 %id)
CX753284 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1460 to 2202 1 to 736     Submitted on the opposite strand 736/825
(89 %)
14 diff
(98.4 %id)
AL524251 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1473 to 2369 895 to 1       895/903
(99 %)
28 diff
(96.9 %id)
CR983077 T-Lymphocytes .b 1486 to 2272 1 to 788       788/788
(100 %)
2 diff
(99.8 %id)
TI_157601784   .b 1502 to 2392 967 to 80   AAA   888/888
(100 %)
27 diff
(97.0 %id)
BU598279 mixed (pool of 40 RNAs) .b 1520 to 2287 1 to 771       771/806
(95 %)
21 diff
(97.4 %id)
TI_1959501479   .b 1530 to 2801 1286 to 11       1276/1287
(99 %)
28 diff
(97.9 %id)
AA374595 lung .b 1533 to 1999 1 to 468       468/468
(100 %)
6 diff
(98.8 %id)
BG681813 skin, squamous cell carcinoma .b 1592 to 2257 1 to 666       666/666
(100 %)
0 diff
(100 %id)
AI871457 anaplastic oligodendroglioma, brain .b 1645 to 2409 764 to 1       764/765
(99 %)
10 diff
(98.7 %id)
BQ188270 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1667 to 2322 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
AW608279 leiomios .b 1689 to 2196 21 to 532       512/532
(96 %)
9 diff
(98.4 %id)
BQ018228 lung, Metastatic Chondrosarcoma .b 1690 to 2400 725 to 17   AAA   709/714
(99 %)
3 diff
(99.6 %id)
TI_149281738   .b 1690 to 2400 794 to 86   AAA   709/713
(99 %)
3 diff
(99.6 %id)
TI_154126613   .b 1690 to 2395 792 to 89   AAA   704/940
(74 %)
3 diff
(99.7 %id)
TI_151764226   .b 1690 to 2423 780 to 53       728/987
(73 %)
7 diff
(99.3 %id)
BQ773955 Bone, Human Chondrosarcoma Cell Line .b 1693 to 2418 724 to 1       724/724
(100 %)
6 diff
(99.2 %id)
CN286319 embryonic stem cells, cell lines H1, H7, andH9 .b 1714 to 2196 1 to 483       483/483
(100 %)
1 diff
(99.8 %id)
BQ050359 leiomyosarcoma, uterus .b 1723 to 2551 1 to 832       832/1057
(78 %)
13 diff
(98.8 %id)
CA416703 Chondrosarcoma Cell line .b 1726 to 2411 685 to 1       685/685
(100 %)
4 diff
(99.5 %id)
BU679689 lung .b 1768 to 2400 648 to 17   AAA   632/632
(100 %)
2 diff
(99.7 %id)
AI950925 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .b 1775 to 2412 636 to 1       636/637
(99 %)
17 diff
(97.4 %id)
CA428255 Bone, Subchondral Bone .b 1783 to 2418 636 to 1       636/636
(100 %)
3 diff
(99.6 %id)
AI431592 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1786 to 2384 603 to 1       603/603
(100 %)
13 diff
(97.9 %id)
CF529324 placenta .b 1788 to 2392 621 to 17   AAA   605/605
(100 %)
0 diff
(100 %id)
BE280867 choriocarcinoma, placenta .b 1808 to 2414 1 to 606       606/679
(89 %)
8 diff
(98.9 %id)
CX756034 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1826 to 2562 1 to 737     Submitted on the opposite strand 737/737
(100 %)
1 diff
(99.9 %id)
BG236457 blood, lymphocyte .b 1834 to 2401 568 to 1       568/568
(100 %)
1 diff
(99.9 %id)
AA873517 2 pooled tumors (clear cell type), Kidney .b 1857 to 2394 537 to 1       537/576
(93 %)
22 diff
(96.2 %id)
AW339244 carcinoid, lung .b 1860 to 2401 542 to 1       542/552
(98 %)
13 diff
(97.7 %id)
AA745490 germinal center B cell .b 1879 to 2414 539 to 5       535/539
(99 %)
1 diff
(99.9 %id)
AA286966 germinal center B cell .b 1885 to 2386 501 to 1     Submitted on the opposite strand 501/501
(100 %)
2 diff
(99.7 %id)
AI032650 liver and spleen .b 1885 to 2401 517 to 1       517/517
(100 %)
5 diff
(99.1 %id)
AI334296 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1888 to 2400 511 to 1       511/511
(100 %)
4 diff
(99.3 %id)
AW411151 muscle, rhabdomyosarcoma .b 1889 to 2213 328 to 4       325/328
(99 %)
0 diff
(100 %id)
AA806499 germinal center B cell .b 1903 to 2409 511 to 6       506/511
(99 %)
3 diff
(99.5 %id)
TI_149282123   .b 1904 to 2404 560 to 60   AAA   501/1258
(39 %)
1 diff
(100.0 %id)
BM983680 lung, Primary Lung Epithelial Cells .b 1904 to 2404 515 to 15   AAA   501/556
(90 %)
1 diff
(99.9 %id)
TI_154036489   .b 1905 to 2423 548 to 30       519/992
(52 %)
0 diff
(100 %id)
AA677239 liver and spleen .b 1924 to 2392 468 to 1       468/468
(100 %)
12 diff
(97.5 %id)
BF155430 head_neck .b 1932 to 2247 319 to 10       310/319
(97 %)
0 diff
(100 %id)
AI033462 liver and spleen .b 1933 to 2401 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
R59458 whole brain .b 1934 to 2284 1 to 357       357/480
(74 %)
7 diff
(98.6 %id)
CX756769 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1940 to 2703 1 to 760     Submitted on the opposite strand 760/761
(99 %)
7 diff
(99.1 %id)
BM997961 lung, Metastatic Chondrosarcoma .b 1956 to 2404 461 to 13   AAA   449/457
(98 %)
0 diff
(100 %id)
CD386782 embryonic trophoblasts, made from WA01 stemcells .b 1961 to 2398 22 to 459   AAA   438/459
(95 %)
1 diff
(99.8 %id)
TI_1959498539   .b 1968 to 3118 1187 to 48     Submitted on the opposite strand 1140/1285
(88 %)
16 diff
(98.8 %id)
AA977703 leiomyosarcoma, soft tissue .b 1968 to 2401 435 to 1       435/436
(99 %)
4 diff
(99.1 %id)
AA403017   .b 1981 to 2123 1 to 143   fully sequenced,   143/143
(100 %)
0 diff
(100 %id)
CN286320 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1988 to 2408 13 to 433       421/435
(96 %)
1 diff
(99.8 %id)
BX371483 Placenta Cot 25-normalized .b 2009 to 2342 334 to 1       334/356
(93 %)
3 diff
(99.2 %id)
BE326801 Kidney .b 2011 to 2401 391 to 1       391/391
(100 %)
1 diff
(99.8 %id)
BF739823 Kidney .b 2011 to 2401 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
AW470884 pooled germ cell tumors .b 2012 to 2404 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
BM693026 eye, Retina Foveal and Macular .b 2014 to 2390 1 to 377   fully sequenced, AAA   377/377
(100 %)
1 diff
(99.8 %id)
AA281571.
matches multiple genes
germinal center B cell .b 2023 to 2400 378 to 1     also hits gene HNRNPH1 378/378
(100 %)
5 diff
(98.7 %id)
AI970317 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 2033 to 2390 370 to 13       358/370
(96 %)
3 diff
(99.2 %id)
AI990248 pooled germ cell tumors .b 2033 to 2404 370 to 1       370/370
(100 %)
2 diff
(99.5 %id)
AW470885 pooled germ cell tumors .b 2033 to 2408 376 to 3       374/376
(99 %)
1 diff
(99.8 %id)
AA411805   .b 2062 to 2406 345 to 1   fully sequenced,   345/345
(100 %)
0 diff
(100 %id)
CA436394 Bone, Subchondral Bone .b 2078 to 2418 341 to 1       341/341
(100 %)
4 diff
(98.9 %id)
TI_1959502877   .b 2091 to 3118 1070 to 48     Submitted on the opposite strand 1023/1247
(82 %)
7 diff
(99.5 %id)
CN484984 eye .b 2096 to 2716 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
AI356256 anaplastic oligodendroglioma, brain .b 2107 to 2404 298 to 1       298/298
(100 %)
3 diff
(99.0 %id)
AA256490 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2119 to 2400 282 to 1       282/282
(100 %)
0 diff
(100 %id)
BQ335020 marrow .b 2126 to 2343 219 to 4       216/219
(98 %)
0 diff
(100 %id)
AI872651 adenocarcinoma, Pancreas .b 2131 to 2405 277 to 1       277/277
(100 %)
4 diff
(98.6 %id)
AA221026 brain, neuroepithelial cells .b 2135 to 2349 1 to 222       220/227
(96 %)
7 diff
(97.0 %id)
BF874620 lung_tumor .b 2149 to 2511 140 to 501       362/501
(72 %)
2 diff
(99.7 %id)
BQ052635 blood, natural killer cells, cell line .b 2160 to 3182 13 to 1042       1030/1054
(97 %)
32 diff
(97.0 %id)
BQ924412 leiomyosarcoma, uterus .b 2179 to 3031 1 to 857       857/858
(99 %)
11 diff
(98.8 %id)
AW150486 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2181 to 2405 226 to 1       226/227
(99 %)
2 diff
(99.2 %id)
BQ881166 epidermoid carcinoma, cell line, salivary gland .b 2196 to 3081 1 to 896   tiling clone,   896/906
(98 %)
21 diff
(97.7 %id)
AA625431 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2200 to 2716 1 to 514       514/514
(100 %)
4 diff
(99.3 %id)
AL570004 placenta, Placenta Cot 25-normalized .b 2217 to 3197 988 to 9       980/988
(99 %)
5 diff
(99.5 %id)
CN286323 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2220 to 2941 1 to 723       723/723
(100 %)
7 diff
(99.1 %id)
BE181910 head_neck .b 2227 to 2536 1 to 309       309/309
(100 %)
10 diff
(96.8 %id)
BU566460 mixed (pool of 40 RNAs) .b 2227 to 2390 1 to 164   AAA   164/164
(100 %)
2 diff
(98.8 %id)
BU730156 eye, Retina Foveal and Macular .b 2253 to 2408 156 to 3   fully sequenced,   154/156
(98 %)
0 diff
(100 %id)
TI_154113892   .b 2305 to 3235 1010 to 93   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 916/930
(98 %)
42 diff
(95.5 %id)
AA314192 colon .b 2369 to 2765 1 to 397       397/397
(100 %)
2 diff
(99.5 %id)
BI026590 marrow .b 2374 to 2803 12 to 441       430/441
(97 %)
2 diff
(99.6 %id)
BI042485 ovary .b 2385 to 2682 1 to 298       298/298
(100 %)
8 diff
(97.4 %id)
BI042489 ovary .b 2385 to 2682 1 to 298       298/300
(99 %)
8 diff
(97.4 %id)
BI042839 ovary .b 2385 to 2809 1 to 425       425/425
(100 %)
5 diff
(98.9 %id)
BG818813 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2393 to 3096 1 to 697       697/697
(100 %)
8 diff
(98.9 %id)
AW043838 pooled .b 2395 to 3234 840 to 4       837/840
(99 %)
37 diff
(95.6 %id)
TI_149310555   .b 2398 to 3244 925 to 89   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 799/955
(83 %)
22 diff
(97.7 %id)
TI_154095738   .b 2401 to 3247 938 to 91       848/1108
(76 %)
11 diff
(99.1 %id)
BM695653 eye, optic nerve .b 2408 to 2910 1 to 503   fully sequenced, Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 503/503
(100 %)
2 diff
(99.7 %id)
BP426129 small intestine .b 2413 to 2604 1 to 193     Submitted on the opposite strand 193/197
(97 %)
4 diff
(98.0 %id)
AA069076 Pancreas .b 2423 to 2771 1 to 355       355/355
(100 %)
11 diff
(97.0 %id)
AA069069 Pancreas .b 2423 to 2746 1 to 337       332/408
(81 %)
23 diff
(94.4 %id)
AA157239   .b 2423 to 2682 1 to 263       263/266
(98 %)
11 diff
(95.9 %id)
BE905789 epithelioid carcinoma, Pancreas .b 2424 to 3069 1 to 648       648/800
(81 %)
6 diff
(99.3 %id)
CN286314 embryonic stem cells, DMSO-treated H9 cellline .b 2446 to 2824 1 to 379       379/379
(100 %)
7 diff
(98.2 %id)
BM713742 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2449 to 2889 1 to 441   fully sequenced, Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 441/441
(100 %)
1 diff
(99.8 %id)
BF792703 adrenal cortex carcinoma, cell line, adrenal gland .b 2473 to 3124 13 to 664       652/811
(80 %)
20 diff
(97.6 %id)
AW385716 leiomios .b 2484 to 3060 20 to 594       575/594
(96 %)
12 diff
(98.0 %id)
AW601625 breast .b 2485 to 3088 1 to 595       595/611
(97 %)
20 diff
(96.8 %id)
AW385778 leiomios .b 2488 to 2932 18 to 461       444/551
(80 %)
12 diff
(97.9 %id)
AW385793 leiomios .b 2488 to 3067 18 to 591       574/591
(97 %)
13 diff
(97.9 %id)
AW580811 leiomios .b 2503 to 3138 1 to 637       637/643
(99 %)
12 diff
(98.2 %id)
BE314464 brain, neuroblastoma .b 2507 to 3178 9 to 678       670/697
(96 %)
10 diff
(98.6 %id)
BF311711 brain, neuroblastoma .b 2509 to 3200 1 to 680       680/881
(77 %)
15 diff
(98.3 %id)
BQ007689 Chondrosarcoma, Left Pelvis .b 2516 to 3234 737 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 719/719
(100 %)
1 diff
(99.9 %id)
AW580957 leiomios .b 2519 to 3132 33 to 644       612/644
(95 %)
2 diff
(99.7 %id)
DB551472 hippocampus .b 2525 to 3246 1 to 722     Submitted on the opposite strand 722/722
(100 %)
7 diff
(99.1 %id)
BU688841 lung .b 2526 to 3244 730 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 674/712
(94 %)
12 diff
(98.4 %id)
BU625128 cell lines, Enchondroma .b 2528 to 3240 731 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 713/713
(100 %)
2 diff
(99.8 %id)
BE261643 brain, neuroblastoma .b 2529 to 3078 1 to 551       551/551
(100 %)
5 diff
(99.1 %id)
CA444684 lung, Metastatic Chondrosarcoma .b 2530 to 3246 733 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 717/717
(100 %)
7 diff
(99.1 %id)
AW610150 stomach .b 2544 to 3138 9 to 607       599/614
(97 %)
5 diff
(99.2 %id)
AA885455 pooled .b 2550 to 3247 687 to 1       687/698
(98 %)
21 diff
(97.0 %id)
AW582678 stomach .b 2557 to 3021 478 to 10       469/478
(98 %)
18 diff
(96.3 %id)
CA439485 lung, Lung Focal Fibrosis .b 2562 to 3244 701 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 683/683
(100 %)
2 diff
(99.8 %id)
CA431737 Bone, Subchondral Bone .b 2566 to 3244 698 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 680/680
(100 %)
4 diff
(99.5 %id)
AI360111 anaplastic oligodendroglioma, brain .b 2567 to 3245 685 to 7       679/685
(99 %)
15 diff
(97.9 %id)
AI376860   .b 2584 to 3245 664 to 3       662/664
(99 %)
1 diff
(99.9 %id)
AI701171 carcinoid, lung .b 2602 to 3234 674 to 40       635/674
(94 %)
15 diff
(97.8 %id)
BE326503 carcinoid, lung .b 2636 to 3237 605 to 5       601/622
(96 %)
15 diff
(97.6 %id)
BU620531 cell lines, Chondrosarcoma .b 2636 to 3237 620 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 602/602
(100 %)
18 diff
(97.1 %id)
AA557147 breast .b 2644 to 3246 605 to 1       605/605
(100 %)
12 diff
(98.1 %id)
CA448860 Chondrosarcoma, Left Pelvis .b 2646 to 3235 608 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 590/591
(99 %)
5 diff
(99.2 %id)
AW582991 Islets of Langerhans, Pancreas .b 2654 to 3191 1 to 538       538/538
(100 %)
14 diff
(97.4 %id)
BQ001297 lung, Metastatic Chondrosarcoma .b 2656 to 3246 607 to 17   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 591/592
(99 %)
0 diff
(100 %id)
AI400060 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2668 to 3228 553 to 1       553/564
(98 %)
17 diff
(97.0 %id)
AI457806 carcinoid, lung .b 2668 to 3241 577 to 3       575/718
(80 %)
3 diff
(99.6 %id)
AW088274 brain, tumor, 5 pooled (see description) .b 2668 to 3246 578 to 1       578/648
(89 %)
11 diff
(98.4 %id)
AI571238 anaplastic oligodendroglioma, brain .b 2669 to 3246 578 to 1       578/649
(89 %)
7 diff
(99.0 %id)
AW189146 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2682 to 3245 565 to 3       563/565
(99 %)
4 diff
(99.3 %id)
BF195612 fibrotheoma, ovary .b 2686 to 3245 563 to 4       560/563
(99 %)
18 diff
(96.9 %id)
AI828563 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2689 to 3244 604 to 48   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 557/557
(100 %)
19 diff
(96.6 %id)
AA748335 germinal center B cell .b 2690 to 3244 555 to 16   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 540/542
(99 %)
24 diff
(95.6 %id)
AA702973 liver and spleen .b 2695 to 3227 524 to 1       524/524
(100 %)
20 diff
(96.2 %id)
BI025144 marrow .b 2698 to 2903 210 to 4       207/211
(98 %)
3 diff
(98.6 %id)
AW340748 pooled .b 2719 to 3245 533 to 7       527/533
(98 %)
0 diff
(100 %id)
AW117610 pooled .b 2728 to 3245 518 to 1       518/521
(99 %)
13 diff
(97.6 %id)
AA410512 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2731 to 3246 519 to 11   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 509/510
(99 %)
13 diff
(97.5 %id)
BG231870 blood, lymphocyte .b 2734 to 3245 512 to 1       512/512
(100 %)
20 diff
(96.1 %id)
BE541682 cervix .b 2757 to 3237 1 to 486       486/486
(100 %)
17 diff
(96.6 %id)
AI089344 uterus .b 2766 to 3244 498 to 21   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 478/481
(99 %)
12 diff
(97.6 %id)
AI074295 senescent fibroblast .b 2767 to 3247 489 to 9   tiling clone,   481/489
(98 %)
3 diff
(99.4 %id)
AI223788 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2772 to 3244 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AI766677 B-cell, chronic lymphotic leukemia .b 2776 to 3241 472 to 3       470/477
(98 %)
4 diff
(99.2 %id)
AA622217 Prostate, prostate tumor .b 2782 to 3244 463 to 1       463/464
(99 %)
2 diff
(99.6 %id)
AA862654 pooled germ cell tumors .b 2784 to 2867 82 to 1       82/82
(100 %)
0 diff
(100 %id)
AA884628 pooled .b 2785 to 3240 455 to 1       455/455
(100 %)
20 diff
(95.7 %id)
AA069005 Pancreas .b 2792 to 3246 452 to 1       452/453
(99 %)
7 diff
(98.5 %id)
DB538979 hippocampus .b 2796 to 3234 1 to 439     Submitted on the opposite strand 439/439
(100 %)
2 diff
(99.6 %id)
AI277017 placenta .b 2796 to 3244 460 to 12   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 449/449
(100 %)
1 diff
(99.8 %id)
AA157339   .b 2799 to 3221 424 to 1       424/424
(100 %)
7 diff
(98.4 %id)
BI042825 ovary .b 2803 to 2923 1 to 121       121/128
(94 %)
2 diff
(98.5 %id)
AI161311 heart .b 2806 to 3245 443 to 4       440/443
(99 %)
0 diff
(100 %id)
AA988220 carcinoid, lung .b 2815 to 3241 428 to 3       426/428
(99 %)
12 diff
(97.2 %id)
AA806394 germinal center B cell .b 2818 to 3231 438 to 26   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 413/413
(100 %)
2 diff
(99.6 %id)
BM676446 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2828 to 3240 431 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
TI_154109724   .b 2855 to 3234 466 to 85   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 382/912
(41 %)
9 diff
(99.1 %id)
AI356610 ovary, tumor, 5 pooled (see description) .b 2859 to 3246 388 to 1       388/388
(100 %)
0 diff
(100 %id)
BQ004697 Chondrosarcoma, Left Pelvis .b 2869 to 3244 395 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 376/377
(99 %)
12 diff
(96.9 %id)
BM666535 eye, optic nerve .b 2880 to 3244 383 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 365/365
(100 %)
0 diff
(100 %id)
AA824465 germinal center B cell .b 2890 to 3227 368 to 33   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 336/336
(100 %)
4 diff
(98.9 %id)
AI651673 pooled germ cell tumors .b 2893 to 3238 356 to 10       347/356
(97 %)
1 diff
(99.8 %id)
AW205258   .b 2916 to 3244 346 to 18   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 329/339
(97 %)
2 diff
(99.5 %id)
C75064   .b 2929 to 3245 323 to 7       317/335
(94 %)
0 diff
(100 %id)
AA069011 Pancreas .b 2929 to 3246 317 to 1       317/323
(98 %)
6 diff
(98.2 %id)
TI_153989086   .b 2929 to 3244 407 to 92   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 316/645
(48 %)
2 diff
(99.7 %id)
AI357063 lymph node, lymphoma, follicular mixed small and largecell .b 2956 to 3241 322 to 37       286/322
(88 %)
0 diff
(100 %id)
AA854410 parathyroid gland, parathyroid tumor .b 2963 to 3247 290 to 7       284/290
(97 %)
0 diff
(100 %id)
AI524481 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 3007 to 3231 251 to 27   AAA   225/279
(80 %)
0 diff
(100 %id)
BX331944 Neuroblastoma Cot 25-normalized .b 3017 to 3245 1 to 228   fully sequenced,   228/228
(100 %)
1 diff
(99.6 %id)
AA419295 ovarian tumor, ovary .b 3023 to 3245 4 to 226   fully sequenced,   223/226
(98 %)
0 diff
(100 %id)
CA447970 Chondrosarcoma, Left Pelvis .b 3044 to 3234 209 to 19   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 191/191
(100 %)
0 diff
(100 %id)
AA411069 ovarian tumor, ovary .b 3081 to 3244 164 to 1   fully sequenced,   164/164
(100 %)
0 diff
(100 %id)
BX393879 Neuroblastoma Cot 25-normalized .b 3112 to 3224 112 to 1   fully sequenced,   112/112
(100 %)
1 diff
(99.2 %id)
AW088960 ovary, tumor, 5 pooled (see description) .b 3158 to 3247 95 to 6       90/95
(94 %)
0 diff
(100 %id)
DB482615 hippocampus .c 1 to 493 2 to 494   tiling clone,   494/494
(100 %)
2 diff
(99.6 %id)
BG289580 bladder, transitional cell papilloma, cell line .c 4 to 604 1 to 601       601/619
(97 %)
2 diff
(99.7 %id)
BQ638430 eye, retina .c 13 to 630 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
AL543541 placenta, Placenta Cot 25-normalized .c 14 to 972 1 to 955       955/955
(100 %)
5 diff
(99.5 %id)
DR001376 fetal brain .c 15 to 767 7 to 761       755/761
(99 %)
3 diff
(99.7 %id)
CX755669 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 18 to 607 1 to 590     Submitted on the opposite strand 590/712
(82 %)
6 diff
(99.2 %id)
TI_1243018235   .c 35 to 1086 18 to 1065       1048/1236
(84 %)
10 diff
(99.2 %id)
BC113420 Brain, cerebral cortex and lung, PCR rescuedclones .c 42 to 1490 1 to 1449   tiling clone,   1449/1449
(100 %)
1 diff
(100.0 %id)
CN286324 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 344 to 898 7 to 562       556/562
(98 %)
1 diff
(99.9 %id)
BM454299 lymph, lymphoma, cell line .c 1159 to 2002 1 to 848   tiling clone,   848/1061
(79 %)
14 diff
(98.7 %id)
CD177433 embryonic trophoblasts, made from WA01 stemcells .c 1542 to 2113 16 to 587   AAA Possibly primed on the genome, locally A rich (18/22 A in genome downstream of last aligned base) 572/587
(97 %)
3 diff
(99.5 %id)
BI117652 lung, small cell carcinoma .c 1675 to 2107 1 to 433   AAA Possibly primed on the genome, locally A rich (18/22 A in genome downstream of last aligned base) 433/433
(100 %)
2 diff
(99.6 %id)
AA877579 colon, colon tumor RER+ .c 1676 to 2117 444 to 1       444/444
(100 %)
9 diff
(98.0 %id)
AA936832 adenocarcinoma, colon .c 1708 to 2119 411 to 1       411/411
(100 %)
5 diff
(98.8 %id)
AW105323 ovary, tumor, 5 pooled (see description) .c 1722 to 2125 404 to 1   tiling clone,   404/404
(100 %)
0 diff
(100 %id)
CV405079 head_neck .d 1 to 447 20 to 466   tiling clone,   447/472
(94 %)
1 diff
(99.8 %id)
AA437048   .d 408 to 780 1 to 373   tiling clone,   373/373
(100 %)
2 diff
(99.5 %id)
AA437317   .d 1576 to 2115 544 to 2   tiling clone,   543/553
(98 %)
15 diff
(97.3 %id)
AB208921 brain .e 1 to 5593 1 to 5593 L214P tiling clone,   5593/5593
(100 %)
2 diff
(100.0 %id)
BE670945 carcinoid, lung .e 1735 to 2291 557 to 1       557/557
(100 %)
0 diff
(100 %id)
BE550863 carcinoid, lung .e 1745 to 2291 547 to 1       547/547
(100 %)
0 diff
(100 %id)
BE220483 carcinoid, lung .e 1788 to 2291 504 to 1       504/504
(100 %)
1 diff
(99.9 %id)
AI914040 carcinoid, lung .e 1830 to 2291 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
AI695018 carcinoid, lung .e 1831 to 2291 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BI043508 ovary .e 2003 to 2315 27 to 340       314/340
(92 %)
0 diff
(100 %id)
BG434474 placenta .e 2048 to 2742 1 to 685       685/685
(100 %)
13 diff
(98.2 %id)
BG413376 Kidney .e 2128 to 2603 480 to 5       476/480
(99 %)
0 diff
(100 %id)
EB385693 eye, optic nerve .e 2152 to 2987 1 to 836       836/836
(100 %)
1 diff
(99.9 %id)
AI352294   .e 2867 to 3218 1 to 348     Submitted on the opposite strand 348/348
(100 %)
5 diff
(98.6 %id)
BF881448 lung_tumor .e 2918 to 3411 32 to 521       490/521
(94 %)
0 diff
(100 %id)
N50268 multiple sclerosis lesions .e 2960 to 3191 1 to 232       232/243
(95 %)
2 diff
(99.2 %id)
AU185872 skin .e 3094 to 3366 273 to 1       273/273
(100 %)
0 diff
(100 %id)
AA046127 uterus .e 3176 to 3378 1 to 204       204/204
(100 %)
2 diff
(99.1 %id)
AW889838 nervous_tumor .e 3254 to 3635 40 to 421       382/421
(90 %)
0 diff
(100 %id)
AW864220 stomach_normal .e 3312 to 3946 646 to 1       657/646
(101 %)
74 diff
(88.6 %id)
N49217 multiple sclerosis lesions .e 3419 to 3845 433 to 1       433/436
(99 %)
7 diff
(98.4 %id)
DB468124 hippocampus .f-u -8 to 715 1 to 723 P121S S147F P160T S161H C163V ...     723/726
(99 %)
13 diff
(98.3 %id)
AK295149 brain .f-u 1 to 1016 7 to 1022 exact tiling clone,   1022/1022
(100 %)
2 diff
(99.9 %id)
AK310836 trachea .f-u 1 to 1471 7 to 1477 exact tiling clone,   1477/1477
(100 %)
2 diff
(99.9 %id)
DA436759 tongue, tumor tissue .f-u 1 to 587 8 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
DB470751 hippocampus .f-u 1 to 663 7 to 668 A98X P154S D159R P160H A172R ...     668/668
(100 %)
10 diff
(98.6 %id)
DA657766   .f-u 1 to 567 8 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA849816 placenta .f-u 1 to 550 8 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DB111158 thymus .f-u 1 to 571 8 to 589   capped   588/588
(100 %)
13 diff
(97.8 %id)
DA246609 brain .f-u 1 to 562 7 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB214616 trachea .f-u 1 to 446 7 to 457   capped   456/456
(100 %)
7 diff
(98.5 %id)
DB233073 trachea .f-u 1 to 574 7 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DB233099 trachea .f-u 1 to 594 7 to 602   capped   601/601
(100 %)
4 diff
(99.4 %id)
DB233594 trachea .f-u 1 to 571 7 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DB280702 uterus .f-u 1 to 538 7 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA125085 cerebellum .f-u 1 to 529 6 to 536   capped   535/535
(100 %)
3 diff
(99.5 %id)
CB151215 cervix, Uterine .f-u 1 to 605 5 to 608       608/608
(100 %)
4 diff
(99.4 %id)
DA136410 alzheimer cortex .f-u 1 to 533 4 to 537   capped   536/536
(100 %)
3 diff
(99.5 %id)
DA447915 tongue, tumor tissue .f-u 1 to 561 4 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA808346 brain .f-u 1 to 574 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DB276661 uterus .f-u 1 to 533 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
TI_57235261   .f-u 2 to 499 26 to 525       500/525
(95 %)
0 diff
(100 %id)
BI908055 leukocyte .f-u 6 to 499 1 to 496       496/496
(100 %)
3 diff
(99.4 %id)
CN286313 embryonic stem cells, cell lines H1, H7, andH9 .f-u 14 to 522 1 to 509       509/509
(100 %)
2 diff
(99.7 %id)
BQ898439 dorsal root ganglia .f-u 22 to 499 1 to 479       479/1280
(37 %)
6 diff
(99.6 %id)
BM508912 insulinoma, Pancreas .f-u 346 to 826 8 to 488       481/488
(98 %)
0 diff
(100 %id)
BQ268246 insulinoma, Pancreas .f-u 346 to 880 8 to 542       535/542
(98 %)
0 diff
(100 %id)
AI040560 liver and spleen .f-u 570 to 914 343 to 1       343/343
(100 %)
2 diff
(99.5 %id)
CA393336 eye, RPE/choroid .f-u 639 to 1172 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BF925811 nervous_tumor .f-u 722 to 953 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
CK906105 Islets of Langerhans, Pancreas .f-u 857 to 1449 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
BM055253 Islets of Langerhans, Pancreas .f-u 873 to 1311 1 to 439       439/439
(100 %)
0 diff
(100 %id)
BM127469 Islets of Langerhans, Pancreas .f-u 873 to 1299 1 to 427       427/427
(100 %)
1 diff
(99.8 %id)
BP432365   .f-u 898 to 1240 7 to 349       343/349
(98 %)
0 diff
(100 %id)
TI_159714711   .f-u 915 to 1748 905 to 83   AAA   823/992
(82 %)
31 diff
(96.9 %id)
BQ636033 eye, retina .f-u 989 to 1100 1 to 112       112/112
(100 %)
4 diff
(96.5 %id)
TI_151797765   .f-u 1000 to 1572 114 to 686       573/1157
(49 %)
19 diff
(98.4 %id)
BQ018725 lung, Metastatic Chondrosarcoma .f-u 1001 to 1748 764 to 19   tiling clone, AAA   746/746
(100 %)
2 diff
(99.8 %id)
BQ000820 lung, Metastatic Chondrosarcoma .f-u 1095 to 1748 672 to 19   AAA   654/662
(98 %)
2 diff
(99.7 %id)
BM665962 eye, fetal eyes .f-u 1105 to 1748 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
BQ267981 insulinoma, Pancreas .f-u 1154 to 1748 613 to 19   AAA   595/595
(100 %)
2 diff
(99.7 %id)
CR737711 carcinoid, lung .f-u 1210 to 1406 1 to 197       197/199
(98 %)
1 diff
(99.5 %id)
BM505543 insulinoma, Pancreas .f-u 1287 to 1748 480 to 19   AAA   462/462
(100 %)
1 diff
(99.8 %id)
BM127187 Islets of Langerhans, Pancreas .f-u 1287 to 1748 479 to 18   AAA   462/462
(100 %)
1 diff
(99.8 %id)
DB536056 hippocampus .f-u 1291 to 1746 1 to 458     Submitted on the opposite strand 458/460
(99 %)
20 diff
(95.7 %id)
BM510030 Pancreas, Purified pancreatic islet .f-u 1309 to 1750 444 to 3       442/444
(99 %)
0 diff
(100 %id)
BM793323 Ascites, stomach .f-u 1395 to 1750 398 to 41     Submitted on the opposite strand 358/398
(89 %)
3 diff
(99.3 %id)
DW415267 Liver .f-u 1498 to 1748 17 to 267       251/313
(80 %)
1 diff
(99.7 %id)
DW437453 Liver .f-u 1498 to 1730 17 to 249       233/249
(93 %)
0 diff
(100 %id)
DW445707 Liver .f-u 1498 to 1701 17 to 220       204/220
(92 %)
0 diff
(100 %id)
AW074777 bone marrow, stem cell 34+/38+ .f-u 1572 to 1744 7 to 179   AAA Submitted on the opposite strand 173/179
(96 %)
0 diff
(100 %id)
BF057948 brain, oligodendroglioma .f-u 1572 to 1744 28 to 200       173/200
(86 %)
0 diff
(100 %id)
TI_154035960   .g 1 to 497 584 to 85 A4P E5K E12S L28F P29H ... tiling clone, AAA   498/785
(63 %)
6 diff
(99.3 %id)
CA444213 lung, Metastatic Chondrosarcoma .g 44 to 497 471 to 19   tiling clone, AAA   453/453
(100 %)
2 diff
(99.6 %id)
DN997547 breast cancer, Mammary gland (cancer tissue) .h 1 to 677 7 to 683 exact tiling clone,   683/683
(100 %)
6 diff
(99.2 %id)
CN286317 embryonic stem cells, DMSO-treated H9 cellline .h 18 to 777 1 to 764 exact     764/764
(100 %)
9 diff
(98.9 %id)
AW405461 lymph .h 30 to 426 8 to 404   fully sequenced,   397/404
(98 %)
0 diff
(100 %id)
TI_154142733   .h 30 to 650 81 to 701 L118F E124*     621/623
(99 %)
14 diff
(97.8 %id)
TI_154132890   .h 267 to 829 671 to 109   AAA   563/724
(77 %)
13 diff
(98.3 %id)
AW575449 lymph .h 396 to 829 451 to 18   tiling clone, fully sequenced, AAA   434/434
(100 %)
2 diff
(99.6 %id)
DA077409 cerebellum .i 1 to 566 2 to 568 G34X A35C P36A V37C Q38A ... tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
CB150839 cervix, Uterine .j-u 1 to 520 1 to 519   tiling clone,   519/519
(100 %)
6 diff
(98.9 %id)
BE929584 placenta_normal .j-u 295 to 628 358 to 30   tiling clone,   329/358
(91 %)
0 diff
(100 %id)
AA225669   .j-u 580 to 933 1 to 359   tiling clone,   359/364
(98 %)
12 diff
(96.8 %id)
AI868312 pooled .k 1 to 398 403 to 4 L2A S3K L4E S5P A6L ... tiling clone,   400/403
(99 %)
12 diff
(97.1 %id)
AI356254 anaplastic oligodendroglioma, brain .l 1 to 364 364 to 1 exact tiling clone,   364/364
(100 %)
0 diff
(100 %id)
AI363055 anaplastic oligodendroglioma, brain .l 1 to 364 364 to 1 exact     364/364
(100 %)
0 diff
(100 %id)
BC142980 Clones donated by RIKEN .m 1 to 3245 1 to 3245 P160H tiling clone, AAA   3245/3245
(100 %)
4 diff
(99.9 %id)
DB535307 hippocampus .m 2521 to 3245 1 to 719     Submitted on the opposite strand 719/719
(100 %)
15 diff
(98.0 %id)
DB539087 hippocampus .m 2574 to 3245 1 to 677     Submitted on the opposite strand 677/677
(100 %)
15 diff
(97.8 %id)
AW072824 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .m 2742 to 3241 500 to 1       500/500
(100 %)
1 diff
(99.8 %id)
W84384 heart .n 1 to 192 1 to 192   tiling clone,   192/192
(100 %)
5 diff
(97.4 %id)
CR744075 liver and spleen .n 214 to 906 1 to 693 exact tiling clone, AAA   693/693
(100 %)
1 diff
(99.9 %id)
R06847 liver and spleen .n 216 to 562 1 to 355   fully sequenced,   355/355
(100 %)
8 diff
(97.8 %id)
R06869 liver and spleen .n 216 to 602 1 to 392   fully sequenced,   392/392
(100 %)
6 diff
(98.5 %id)
W90266 liver and spleen .n 216 to 663 1 to 452 R18P Q19S S20E R21P R22D ... fully sequenced,   452/452
(100 %)
3 diff
(99.4 %id)
AL044229 testis .n 313 to 842 9 to 538 exact     530/538
(98 %)
0 diff
(100 %id)
AW341311 carcinoid, lung .n 403 to 905 505 to 3 exact     503/505
(99 %)
0 diff
(100 %id)
AI681706 carcinoid, lung .n 422 to 903 482 to 1 K37X     482/482
(100 %)
1 diff
(99.8 %id)
AI421359 brain, glioblastoma (pooled) .n 444 to 906 463 to 1 M34N R35E P36A K37E I38N tiling clone,   463/463
(100 %)
3 diff
(99.4 %id)
W84889 heart .n 449 to 908 459 to 1 exact     459/460
(99 %)
3 diff
(99.4 %id)
R06848 liver and spleen .n 532 to 906 400 to 15   fully sequenced, AAA   386/386
(100 %)
11 diff
(97.2 %id)
R06870 liver and spleen .n 571 to 906 374 to 38   fully sequenced, AAA   337/337
(100 %)
6 diff
(98.3 %id)
W90530 liver and spleen .n 642 to 907 265 to 1   fully sequenced,   265/265
(100 %)
1 diff
(99.7 %id)
BE386973 melanotic melanoma, skin .o -10 to 614 33 to 666 S30I S31L S32I T33D D34R ...     634/666
(95 %)
23 diff
(96.6 %id)
CN286316 embryonic stem cells, cell lines H1, H7, andH9 .o -8 to 627 1 to 636 exact     636/636
(100 %)
3 diff
(99.6 %id)
BG334518 melanotic melanoma, skin .o 1 to 600 7 to 609 exact     609/869
(70 %)
11 diff
(98.8 %id)
BG478212 melanotic melanoma, skin .o 1 to 651 7 to 660 exact tiling clone,   660/722
(91 %)
11 diff
(98.5 %id)
BG477406 melanotic melanoma, skin .o 1 to 653 7 to 661 W13G L14S R15G N16T R17G ...     661/718
(92 %)
17 diff
(97.7 %id)
DA706648   .o 1 to 538 8 to 546 exact capped   545/545
(100 %)
3 diff
(99.5 %id)
BE410462 choriocarcinoma, placenta .o 2 to 654 1 to 656 exact     656/705
(93 %)
9 diff
(98.8 %id)
CN286322 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o 12 to 625 1 to 614 exact     614/614
(100 %)
2 diff
(99.7 %id)
BF304750 muscle, rhabdomyosarcoma .o 13 to 654 1 to 648 exact     648/849
(76 %)
15 diff
(98.3 %id)
BF305654 muscle, rhabdomyosarcoma .o 13 to 618 1 to 607 exact     607/621
(97 %)
8 diff
(98.8 %id)
BI114328 muscle, rhabdomyosarcoma .o 13 to 581 1 to 572 exact     572/575
(99 %)
11 diff
(98.1 %id)
BE727512 melanotic melanoma, skin .o 14 to 659 1 to 679 P2Y S4W C5Q S6A G7C ... available from MGC,   677/958
(70 %)
47 diff
(95.1 %id)
BE276605 melanotic melanoma, skin .o 15 to 600 1 to 596 exact     596/596
(100 %)
13 diff
(97.9 %id)
BE729766 melanotic melanoma, skin .o 15 to 654 1 to 631 W13G L14S R15G N16T R17G ...     631/722
(87 %)
22 diff
(97.0 %id)
CN286318 embryonic stem cells, cell lines H1, H7, andH9 .o 25 to 639 1 to 616 exact tiling clone,   616/616
(100 %)
4 diff
(99.4 %id)
BG914228 anaplastic oligodendroglioma with 1p/19qloss, brain .o 26 to 654 31 to 671 exact     638/878
(72 %)
15 diff
(98.3 %id)
BQ229037 embryonal carcinoma, cell line, testis .o 32 to 648 14 to 633 E66R tiling clone, AAA   620/633
(97 %)
15 diff
(97.7 %id)
CO246088 Chondrosarcoma Lung Metastasis cell lines, lung .o 36 to 664 7 to 634 exact     628/786
(79 %)
12 diff
(98.5 %id)
DB231773 trachea .p-u 1 to 564 2 to 565 H13R tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
DB470699 hippocampus Gene SFRS8, variant not shown         This clone was ignored    
BE699064 nervous_normal Gene SFRS8, variant not shown         This clone was ignored    
BM503889 Pancreas, Purified pancreatic islet Gene SFRS8, variant not shown         Suspected internal deletion, this clone was ignored    
AA027262 heart Gene SFRS8, variant not shown         This clone was ignored    
AA027263 heart Gene SFRS8, variant not shown         This clone was ignored    
AA812028 germinal center B cell Gene SFRS8, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BG754452 B-cells, primary B-cells from tonsils (cell line) Gene SFRS8, variant not shown         This clone was ignored    
BQ127978 insulinoma, Pancreas Gene SFRS8, variant not shown         Suspected internal deletion, this clone was ignored    
BQ228882 melanotic melanoma, skin Gene SFRS8, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI